Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.9 USD | +0.92% | -0.90% | -16.81% |
Sales 2024 | 1,604B 10.32B 808B | Sales 2025 * | 1,676B 10.79B 845B | Capitalization | 2,793B 17.98B 1,408B |
---|---|---|---|---|---|
Net income 2024 | 17.04B 110M 8.59B | Net income 2025 * | 81.86B 527M 41.26B | EV / Sales 2024 | 1.63 x |
Net Debt 2024 | 336B 2.16B 169B | Net Debt 2025 * | 479B 3.09B 242B | EV / Sales 2025 * | 1.95 x |
P/E ratio 2024 |
173
x | P/E ratio 2025 * |
34.1
x | Employees | 14,484 |
Yield 2024 |
4.26% | Yield 2025 * |
4.81% | Free-Float | 98.84% |
Latest transcript on Astellas Pharma Inc.
1 day | +0.92% | ||
1 week | -0.90% | ||
Current month | +0.92% | ||
1 month | -1.39% | ||
3 months | -11.21% | ||
6 months | -19.38% | ||
Current year | -16.81% |
Managers | Title | Age | Since |
---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 61 | 31/03/86 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 52 | 10-31 |
Kenji Yasukawa
CHM | Chairman | 64 | 31/03/86 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takashi Tanaka
BRD | Director/Board Member | 67 | 31/05/21 |
Mamoru Sekiyama
BRD | Director/Board Member | 74 | 31/05/17 |
Naoki Okamura
CEO | Chief Executive Officer | 61 | 31/03/86 |
Date | Price | Change | Volume |
---|---|---|---|
03/06/24 | 9.9 | +0.92% | 313,426 |
31/05/24 | 9.81 | +1.24% | 508,631 |
30/05/24 | 9.69 | +0.41% | 628,777 |
29/05/24 | 9.65 | -2.53% | 243,492 |
Delayed Quote OTC Markets, June 03, 2024 at 08:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.60% | 748B | |
+33.16% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.83% | 245B | |
+8.60% | 211B | |
-4.38% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- 4503 Stock
- ALPMY Stock